MA39792B1 - Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) - Google Patents
Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)Info
- Publication number
- MA39792B1 MA39792B1 MA39792A MA39792A MA39792B1 MA 39792 B1 MA39792 B1 MA 39792B1 MA 39792 A MA39792 A MA 39792A MA 39792 A MA39792 A MA 39792A MA 39792 B1 MA39792 B1 MA 39792B1
- Authority
- MA
- Morocco
- Prior art keywords
- disorders
- inhibitors
- lpa
- autotaxin
- atx
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 title abstract 2
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 title abstract 2
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 title abstract 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 title abstract 2
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 230000001684 chronic effect Effects 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention propose de nouveaux composés répondant à la formule générale (i) dans laquelle r1, r2, a, w, m, n, p et q sont tels que décrits dans la présente, des compositions comprenant les composés. Les composés de formule (i) sont utiles en tant qu’inhibiteurs de l’autotaxine (atx), inhibiteurs de la production d’acide lysophosphatidique (lpa) et donc modulateurs des taux de lpa et de la signalisation associée; en particulier, ils sont utiles pour le traitement ou la prophylaxie des affections rénales, des affections du foie, des affections inflammatoires, des affections du système nerveux, des affections du système respiratoire, des affections vasculaires et cardiovasculaires, des affections fibrotiques, du cancer, des affections oculaires, des affections métaboliques, du cholestérol et autres formes de prurit chronique et de rejet aigu et chronique de greffes d'organes.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14161760 | 2014-03-26 | ||
| EP15711203.8A EP3122750B1 (fr) | 2014-03-26 | 2015-03-23 | Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) |
| PCT/EP2015/056032 WO2015144605A1 (fr) | 2014-03-26 | 2015-03-23 | Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39792B1 true MA39792B1 (fr) | 2019-12-31 |
Family
ID=50389849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050635A MA50635A (fr) | 2014-03-26 | 2015-03-23 | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
| MA39792A MA39792B1 (fr) | 2014-03-26 | 2015-03-23 | Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa) |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050635A MA50635A (fr) | 2014-03-26 | 2015-03-23 | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
Country Status (29)
| Country | Link |
|---|---|
| US (4) | US9802944B2 (fr) |
| EP (2) | EP3590939A1 (fr) |
| JP (2) | JP6553637B2 (fr) |
| KR (1) | KR20160128345A (fr) |
| CN (2) | CN110204550B (fr) |
| AR (1) | AR099824A1 (fr) |
| AU (2) | AU2015238537B2 (fr) |
| CA (1) | CA2937616A1 (fr) |
| CL (1) | CL2016002310A1 (fr) |
| CR (1) | CR20160419A (fr) |
| DK (1) | DK3122750T3 (fr) |
| EA (1) | EA037928B1 (fr) |
| ES (1) | ES2753549T3 (fr) |
| HR (1) | HRP20191936T1 (fr) |
| HU (1) | HUE046820T2 (fr) |
| IL (1) | IL246708B (fr) |
| LT (1) | LT3122750T (fr) |
| MA (2) | MA50635A (fr) |
| MX (1) | MX370659B (fr) |
| PE (1) | PE20161134A1 (fr) |
| PH (2) | PH12016501632A1 (fr) |
| PL (1) | PL3122750T3 (fr) |
| PT (1) | PT3122750T (fr) |
| RS (1) | RS59477B1 (fr) |
| SG (1) | SG11201607839UA (fr) |
| SI (1) | SI3122750T1 (fr) |
| TW (1) | TWI708774B (fr) |
| UA (1) | UA118582C2 (fr) |
| WO (1) | WO2015144605A1 (fr) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2861566T1 (sl) | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
| PL2900669T3 (pl) | 2012-09-25 | 2020-01-31 | F. Hoffmann-La Roche Ag | Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| US9540324B2 (en) * | 2013-09-26 | 2017-01-10 | Luc Therapeutics, Inc. | Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B |
| AU2014356583B2 (en) | 2013-11-26 | 2019-02-28 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl |
| DK3102576T3 (da) | 2014-02-03 | 2019-07-22 | Vitae Pharmaceuticals Llc | Dihydropyrrolopyridininhibitorer af ror-gamma |
| CR20160418A (es) | 2014-03-26 | 2016-11-07 | Hoffmann La Roche | Nuevos compuestos biciclicos de 7 eslabones |
| MA50635A (fr) * | 2014-03-26 | 2020-08-12 | Hoffmann La Roche | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
| JO3579B1 (ar) | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| EP3331876B1 (fr) | 2015-08-05 | 2020-10-07 | Vitae Pharmaceuticals, LLC | Modulateurs de ror-gamma |
| EP3344619B1 (fr) | 2015-09-04 | 2020-10-28 | H. Hoffnabb-La Roche Ag | Dérivés phénoxyméthyles |
| WO2017050747A1 (fr) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs doubles d'atx/ca |
| AU2016328437A1 (en) | 2015-09-24 | 2018-01-25 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
| BR112018006080A2 (pt) | 2015-09-24 | 2018-10-09 | F. Hoffmann-La Roche Ag | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| EP3868750A1 (fr) | 2015-11-20 | 2021-08-25 | Vitae Pharmaceuticals, LLC | Modulateurs de ror-gamma |
| CU20180056A7 (es) | 2015-12-10 | 2018-10-04 | Bayer Pharma AG | Derivados de 2-fenil-3-(piperazinometil)imidazo(1,2-a)piridina como bloqueadores de los canales task-1 y task-2 para el tratamiento de trastornos respiratorios |
| WO2017097671A1 (fr) | 2015-12-10 | 2017-06-15 | Bayer Pharma Aktiengesellschaft | Dérivés de perhydropyrrolo[3,4-c]pyrrole substitués et leur utilisation |
| TWI757266B (zh) | 2016-01-29 | 2022-03-11 | 美商維它藥物有限責任公司 | ROR-γ調節劑 |
| JOP20190005A1 (ar) | 2016-07-20 | 2019-01-20 | Bayer Ag | مركبات ديازاهيترو ثنائية الحلقة مستبدلة واستخداماتها |
| CN108456208B (zh) * | 2017-02-22 | 2021-04-16 | 广州市恒诺康医药科技有限公司 | 氮杂螺环类化合物及其制备方法和应用 |
| RU2019132254A (ru) * | 2017-03-16 | 2021-04-16 | Ф. Хоффманн-Ля Рош Аг | Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca |
| EP3596060B1 (fr) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| AR111295A1 (es) | 2017-03-20 | 2019-06-26 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr) |
| KR101798840B1 (ko) * | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
| WO2018227427A1 (fr) | 2017-06-14 | 2018-12-20 | Bayer Aktiengesellschaft | Dérivés de diazépane pontés substitués et leur utilisation |
| JOP20190284A1 (ar) | 2017-06-14 | 2019-12-11 | Bayer Pharma AG | مركبات إيميدازوبيريميدين مستبدلة بديازا ثنائي الحلقة واستخدامها للمعالجة من اضطرابات التنفس |
| CN115716826A (zh) | 2017-07-24 | 2023-02-28 | 生命医药有限责任公司 | RORγ的抑制剂 |
| WO2019018975A1 (fr) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | Inhibiteurs de ror gamma |
| EP3728234B1 (fr) | 2017-12-21 | 2025-05-14 | F. Hoffmann-La Roche AG | Composés radiomarqués |
| WO2020061255A1 (fr) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activation de la pyruvate kinase r |
| US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| CN113412113B (zh) * | 2018-12-11 | 2024-07-26 | 豪夫迈·罗氏有限公司 | 氨基嗪酰胺 |
| WO2020119896A1 (fr) * | 2018-12-11 | 2020-06-18 | F. Hoffmann-La Roche Ag | Inhibiteurs hétérocycliques d'atx |
| CA3149062A1 (fr) * | 2019-09-06 | 2021-03-11 | Xuejun Zhang | Compose de pyrimidine et son procede de preparation |
| MX2022003025A (es) | 2019-09-19 | 2022-04-07 | Forma Therapeutics Inc | Activacion de la piruvato cinasa r. |
| CN113943276B (zh) * | 2020-07-16 | 2025-09-23 | 武汉人福创新药物研发中心有限公司 | 氮杂环类化合物及其用途 |
| FI4274572T3 (fi) | 2021-01-05 | 2026-03-27 | Zydus Lifesciences Ltd | Uusia autotaksiinin inhibiittoreita |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| MX2023013961A (es) | 2021-10-01 | 2023-12-11 | Nextgen Bioscience Co Ltd | Nuevos derivados de la piperidina y composiciones farmaceuticas que los contienen, para inhibir la autotaxina. |
| TW202329937A (zh) | 2021-12-03 | 2023-08-01 | 美商英塞特公司 | 雙環胺ck12抑制劑 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| KR102587919B1 (ko) | 2022-07-22 | 2023-10-11 | 주식회사 넥스트젠바이오사이언스 | 신규한 헤테로사이클릭 화합물 및 이를 포함하는 오토탁신 저해용 약학 조성물 |
| JP2026511574A (ja) | 2023-03-31 | 2026-04-14 | ネクストジェン バイオサイエンス カンパニー リミテッド | 新規なアザビサイクル誘導体及びそれを含むオートタキシン阻害用薬学組成物 |
| CN119320383A (zh) * | 2023-09-05 | 2025-01-17 | 北京鞍石生物科技股份有限公司 | 含氮杂芳基化合物及其制备方法和应用 |
Family Cites Families (148)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1252898B (de) | 1965-06-12 | 1967-10-26 | Bayer Ag | Verfahren zur Herstellung von Copolymerisaten des Trioxans |
| IT1176613B (it) | 1984-08-14 | 1987-08-18 | Ravizza Spa | Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione |
| US5240928A (en) | 1989-07-03 | 1993-08-31 | Merck & Co., Inc. | Substituted quinazolinones as angiotensin II antagonists |
| DE3930262A1 (de) | 1989-09-11 | 1991-03-21 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| KR910009330B1 (ko) | 1989-10-23 | 1991-11-11 | 재단법인 한국화학연구소 | 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법 |
| CA2037630C (fr) | 1990-03-07 | 2001-07-03 | Akira Morimoto | Composes heterocycliques renfermant de l'azote, methode de production et applications correspondantes |
| US5470975A (en) | 1990-10-16 | 1995-11-28 | E.R. Squibb & Sons, Inc. | Dihydropyrimidine derivatives |
| US5290780A (en) | 1991-01-30 | 1994-03-01 | American Cyanamid Co. | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| US5238942A (en) | 1991-05-10 | 1993-08-24 | Merck & Co., Inc. | Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists |
| DE4121214A1 (de) | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| US5202322A (en) | 1991-09-25 | 1993-04-13 | Merck & Co., Inc. | Quinazolinone and pyridopyrimidine a-II antagonists |
| US5532243A (en) | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
| US5358951A (en) | 1993-04-23 | 1994-10-25 | American Cyanamid Company | Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones |
| DE4407047A1 (de) | 1994-03-03 | 1995-09-07 | Merck Patent Gmbh | Acetamide |
| US20010016657A1 (en) | 1997-03-18 | 2001-08-23 | Smithkline Beecham P.L.C. | Substituted isoquinoline derivatives and their use as anticonvulsants |
| CN1290251A (zh) | 1998-02-04 | 2001-04-04 | 万有制药株式会社 | N-酰基环胺衍生物 |
| JP2001039950A (ja) | 1999-07-30 | 2001-02-13 | Banyu Pharmaceut Co Ltd | N−アシル環状アミン誘導体 |
| WO2001030780A2 (fr) | 1999-10-27 | 2001-05-03 | Cor Therapeutics, Inc. | Composes spirocycliques pyridiles inhibiteurs de l'agregation plaquettaire dependant des fibrinogenes |
| PT1233787E (pt) | 1999-11-09 | 2005-04-29 | Conseils Rech S Et D Applic Sc | Produto contendo um inibidor da transducao dos sinais das proteinas g heterotrimericas em associacao com um outro agente anticanceroso para utilizacao terapeutica no tratamento do cancro |
| WO2002070523A1 (fr) * | 2001-03-07 | 2002-09-12 | Pfizer Products Inc. | Modulateurs de l'activite du recepteur de la chimiokine |
| EP1499306A4 (fr) | 2002-04-12 | 2007-03-28 | Merck & Co Inc | Amides bicycliques |
| KR20050051691A (ko) | 2002-10-11 | 2005-06-01 | 아스트라제네카 아베 | 1,4-이치환 피페리딘 유도체 및 11-베타hsd1억제제로서의 이들의 용도 |
| GB0303852D0 (en) | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
| WO2005023762A1 (fr) | 2003-09-04 | 2005-03-17 | Abbott Laboratories | Derives de pyrrolidine-2-carbonitrile et leur utilisation comme inhibiteurs de la dipeptidyle peptidase-iv (dpp-iv) |
| SE0302811D0 (sv) | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
| GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
| US7226951B2 (en) | 2003-12-17 | 2007-06-05 | Allergan, Inc. | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| KR100610731B1 (ko) | 2004-02-24 | 2006-08-09 | 한국과학기술연구원 | T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법 |
| AU2005219438B2 (en) * | 2004-03-03 | 2011-02-17 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| ATE382623T1 (de) | 2004-06-09 | 2008-01-15 | Hoffmann La Roche | Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln |
| AU2005271161B2 (en) | 2004-08-10 | 2011-05-12 | Janssen Pharmaceutica N.V. | HIV inhibiting 1,2,4-triazin-6-one derivatives |
| US7410949B2 (en) | 2005-01-18 | 2008-08-12 | Hoffmann-La Roche Inc. | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
| GB0504019D0 (en) | 2005-02-26 | 2005-04-06 | Astrazeneca Ab | Amide derivatives |
| MX2007013469A (es) | 2005-04-28 | 2008-01-22 | Wyeth Corp | Forma ii polimorfa de tanaproget. |
| US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| TW200800999A (en) | 2005-09-06 | 2008-01-01 | Astrazeneca Ab | Novel compounds |
| GEP20115230B (en) | 2005-09-23 | 2011-06-10 | Pfizer Prod Inc | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 |
| WO2007049771A1 (fr) | 2005-10-28 | 2007-05-03 | Ono Pharmaceutical Co., Ltd. | Compose contenant un groupe basique et son utilisation |
| PT1961744E (pt) | 2005-11-18 | 2013-05-15 | Ono Pharmaceutical Co | Composto que contém um grupo básico e sua utilização |
| JP2007176809A (ja) | 2005-12-27 | 2007-07-12 | Hideaki Natsukari | 複素環置換アミド化合物、その製造法および医薬組成物 |
| RU2008136763A (ru) * | 2006-02-15 | 2010-03-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Гетероциклические противовирусные соединения |
| US20070208001A1 (en) | 2006-03-03 | 2007-09-06 | Jincong Zhuo | Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| JP2008031064A (ja) | 2006-07-27 | 2008-02-14 | Astellas Pharma Inc | ジアシルピペラジン誘導体 |
| NZ575426A (en) | 2006-09-11 | 2010-09-30 | Organon Nv | Quinazolinone and isoquinolinone acetamide derivatives useful for the treatment of disorders which are influenced by modulation of the activity of the hpa axis |
| JP2010503675A (ja) | 2006-09-15 | 2010-02-04 | シェーリング コーポレイション | 疼痛、糖尿病および脂質代謝の障害の治療に有用なスピロ縮合アゼチジン誘導体 |
| ES2345130T3 (es) * | 2006-09-18 | 2010-09-15 | F. Hoffmann-La Roche Ag | Derivados de octahidropirrolo(3,4-c)pirrol y su uso como antiviricos. |
| US8735411B2 (en) | 2006-10-02 | 2014-05-27 | Abbvie Inc. | Macrocyclic benzofused pyrimidine derivatives |
| TWI405763B (zh) | 2006-11-02 | 2013-08-21 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
| WO2008059026A1 (fr) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Nouveaux 2-(2-hydroxyphényl)benzimidazoles utilisés pour traiter l'obésité et le diabète |
| TW200831085A (en) | 2006-12-13 | 2008-08-01 | Merck & Co Inc | Non-nucleoside reverse transcriptase inhibitors |
| EP1975165A1 (fr) | 2007-03-27 | 2008-10-01 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pyrrolidinamide substituée, sa fabrication et son utilisation en tant que médicament |
| MX2009009920A (es) | 2007-03-29 | 2009-10-19 | Hoffmann La Roche | Inhibidores no nucleosidos de transcriptasa inversa. |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| US7909939B2 (en) | 2007-04-25 | 2011-03-22 | Illinois Tool Works, Inc. | Humidity reducing exhaust duct for dishwasher |
| JP2010524987A (ja) | 2007-04-27 | 2010-07-22 | サノフィ−アベンティス | 2−ヘテロアリール−ピロロ[3,4−c]ピロール誘導体及びscd阻害剤としてのそれらの使用 |
| AU2008285652B2 (en) | 2007-08-07 | 2013-09-05 | AbbVie Deutschland GmbH & Co. KG | Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| DE102007047737A1 (de) | 2007-10-05 | 2009-04-30 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| CA2702984C (fr) | 2007-10-19 | 2017-04-11 | Sarcode Corporation | Compositions et procedes pour le traitement de la retinopathie diabetique |
| PE20091017A1 (es) | 2007-10-31 | 2009-07-16 | Janssen Pharmaceutica Nv | Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa |
| JP2009161449A (ja) | 2007-12-28 | 2009-07-23 | Lion Corp | Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬 |
| AU2009261248A1 (en) | 2008-06-19 | 2009-12-23 | Banyu Pharmaceutical Co., Ltd. | Spirodiamine-diarylketoxime derivative |
| WO2010028761A1 (fr) | 2008-09-09 | 2010-03-18 | Sanofi-Aventis | Dérivés de 2-hétéro-aryl-pyrrolo[3, 4-c]pyrrol et leur utilisation en tant qu'inhibiteurs de scd |
| TW201020247A (en) | 2008-11-06 | 2010-06-01 | Gruenenthal Gmbh | Substituierte disulfonamide |
| JP5373104B2 (ja) | 2008-11-17 | 2013-12-18 | エフ.ホフマン−ラ ロシュ アーゲー | Crth2アンタゴニスト又は部分アゴニストとして使用されるナフチル酢酸 |
| DE102008059578A1 (de) | 2008-11-28 | 2010-06-10 | Merck Patent Gmbh | Benzo-Naphtyridin Verbindungen |
| US8530650B2 (en) | 2008-12-01 | 2013-09-10 | Merck Patent Gmbh | 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer |
| TW201035102A (en) | 2009-03-04 | 2010-10-01 | Gruenethal Gmbh | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| CA2754446A1 (fr) | 2009-03-05 | 2010-09-10 | Daiichi Sankyo Company, Limited | Derive de pyridine |
| US20120010186A1 (en) | 2009-03-23 | 2012-01-12 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| TW201038572A (en) | 2009-03-25 | 2010-11-01 | Gruenenthal Gmbh | Substituted spiro-amide compounds |
| JP5767205B2 (ja) | 2009-04-02 | 2015-08-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | オートタキシン阻害剤としての複素環式化合物 |
| AU2010234087B2 (en) * | 2009-04-02 | 2016-05-12 | Merck Patent Gmbh | Piperidine and piperazine derivatives as autotaxin inhibitors |
| US8329907B2 (en) * | 2009-04-02 | 2012-12-11 | Merck Patent Gmbh | Autotaxin inhibitors |
| FR2945534B1 (fr) | 2009-05-12 | 2012-11-16 | Sanofi Aventis | DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| WO2010135524A1 (fr) | 2009-05-22 | 2010-11-25 | Exelixis, Inc. | Inhibiteurs de pi3k/mtor à base de benzoxazépines pour lutter contre les maladies prolifératives |
| US20120083476A1 (en) | 2009-06-05 | 2012-04-05 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
| DE102009033392A1 (de) | 2009-07-16 | 2011-01-20 | Merck Patent Gmbh | Heterocyclische Verbindungen als Autotaxin-Inhibitoren II |
| JP2013501064A (ja) | 2009-08-04 | 2013-01-10 | アミラ ファーマシューティカルス,インコーポレーテッド | リゾホスファチジン酸受容体アンタゴニストとしての化合物 |
| UA107360C2 (en) | 2009-08-05 | 2014-12-25 | Biogen Idec Inc | Bicyclic aryl sphingosine 1-phosphate analogs |
| AR079022A1 (es) | 2009-11-02 | 2011-12-21 | Sanofi Aventis | Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion |
| ES2534516T3 (es) | 2010-01-07 | 2015-04-23 | E.I. Du Pont De Nemours And Company | Compuestos heterocíclicos fungicidas |
| US8815869B2 (en) | 2010-03-18 | 2014-08-26 | Abbvie Inc. | Lactam acetamides as calcium channel blockers |
| ES2557895T3 (es) | 2010-03-19 | 2016-01-29 | Pfizer Inc | Derivados de 2,3-dihidro-1H-inden-1-il-2,7-diazaespiro[3.6]nonano y su uso como antagonistas o agonistas inversos del receptor de grelina |
| WO2011116867A1 (fr) | 2010-03-26 | 2011-09-29 | Merck Patent Gmbh | Benzonaphthyridinamines en tant qu'inhibiteurs d'autotaxine |
| GB201008005D0 (en) | 2010-05-13 | 2010-06-30 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| EP2575794A2 (fr) | 2010-06-04 | 2013-04-10 | B.S.R.C. "Alexander Fleming" | Modulation de la voie autotaxine et utilisations correspondantes |
| AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
| EP2606031B1 (fr) | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Inhibiteurs de l'autotaxine et leurs utilisations |
| JP6039559B2 (ja) | 2010-09-02 | 2016-12-07 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Lpa受容体アンタゴニストとしてのピラゾロピリジノン誘導体 |
| EP2646428B1 (fr) | 2010-12-02 | 2016-06-01 | Shanghai De Novo Pharmatech Co Ltd. | Dérivés hétérocycliques, leurs procédés de préparation et leurs utilisations médicales |
| EP2651405A2 (fr) | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Inhibiteurs de caséine kinase 1 (ck1 ) |
| CN103596947A (zh) * | 2011-04-05 | 2014-02-19 | 艾米拉医药股份有限公司 | 用于治疗纤维化、疼痛、癌症和呼吸、过敏性、神经系统疾病或心血管疾病的基于3-或5-联苯-4-基异噁唑的化合物 |
| US9260416B2 (en) | 2011-05-27 | 2016-02-16 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
| WO2013033059A1 (fr) | 2011-08-29 | 2013-03-07 | Bristol-Myers Squibb Company | Dérivés spiraniques de diamine bicyclique utilisés en tant qu'inhibiteurs de la fixation du vih |
| WO2013054185A1 (fr) | 2011-10-13 | 2013-04-18 | Pfizer, Inc. | Dérivés de pyrimidine et de pyridine utiles en thérapie |
| JPWO2013065712A1 (ja) | 2011-10-31 | 2015-04-02 | 東レ株式会社 | ジアザスピロウレア誘導体及びその医薬用途 |
| US8809552B2 (en) | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
| EP2800745B1 (fr) | 2011-12-02 | 2020-02-12 | Phenex Pharmaceuticals AG | Pyrroloarboxamides comme modulateurs de l'activité de récepteur-gamma orphelin (rory, nr1f3) associé au rar de récepteur nucléaire orphelin et pour le traitement des maladies inflammatoires et de maladies auto-immunes chroniques |
| TWI638802B (zh) | 2012-05-24 | 2018-10-21 | 芬蘭商奧利安公司 | 兒茶酚o-甲基轉移酶活性抑制化合物 |
| CA2876689C (fr) | 2012-06-13 | 2022-04-26 | Incyte Corporation | Composes tricycliques substitues utilises comme inhibiteurs de fgfr |
| SI2861566T1 (sl) | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
| KR20150028999A (ko) | 2012-06-27 | 2015-03-17 | 에프. 호프만-라 로슈 아게 | 5-아자인다졸 화합물 및 이의 사용 방법 |
| ES2668694T3 (es) | 2012-07-27 | 2018-05-21 | Biogen Ma Inc. | Derivados de ácido 1-[7-(cis-4-metil-ciclohexiloxi)-8-trifluorometil-naftalen-2-ilmetil]-piperidin-4-carboxílico como moduladores de autotaxina (ATX) para tratar inflamaciones y trastornos autoinmunitarios |
| BR112015001613B1 (pt) | 2012-07-27 | 2021-02-23 | Biogen Ma Inc | compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx, seus usos e composição farmacêutica |
| AR092211A1 (es) | 2012-09-24 | 2015-04-08 | Merck Patent Ges Mit Beschränkter Haftung | Derivados de hidropirrolopirrol |
| HRP20181462T1 (hr) | 2012-09-25 | 2018-11-02 | Bayer Pharma Aktiengesellschaft | Kombinacija regorafeniba i acetilsalicilne kiseline za liječenje raka debelog crijeva |
| PL2900669T3 (pl) | 2012-09-25 | 2020-01-31 | F. Hoffmann-La Roche Ag | Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| WO2014066659A1 (fr) | 2012-10-25 | 2014-05-01 | Tetra Discovery Partners, Llc. | Inhibiteurs hétéroaryle de pde4 |
| MX2015006780A (es) | 2012-12-31 | 2015-08-06 | Cadila Healthcare Ltd | Derivados de ftalazin-1-(2h)-ona sustituida. |
| US20160002247A1 (en) | 2013-03-01 | 2016-01-07 | The University Of Tokyo | 8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity |
| BR112015022391B1 (pt) | 2013-03-12 | 2021-12-21 | Abbvie Inc | Compostos inibidores do domínio bromo tetracíclico, composição farmacêutica que compreende os referidos compostos e usos terapêuticos dos mesmos |
| AU2014248878A1 (en) | 2013-03-12 | 2015-09-24 | Acucela Inc. | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders |
| AR095079A1 (es) * | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| TWI593692B (zh) | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
| TW201446768A (zh) | 2013-03-15 | 2014-12-16 | Biogen Idec Inc | S1p及/或atx調節劑 |
| EP2991994B1 (fr) | 2013-05-01 | 2018-08-15 | Vitae Pharmaceuticals, Inc. | Inhibiteurs du ror-gamma à base de thiazolopyrrolidine |
| PT3022202T (pt) | 2013-07-18 | 2019-09-03 | Novartis Ag | Inibidores da autotaxina compreendendo um núcleo beteroaromático anel-benzilo-amida-ciclo |
| SI3057959T1 (en) | 2013-10-17 | 2018-07-31 | Vertex Pharmaceuticals Incorporated | DNA-PK INHIBITORS |
| PE20160654A1 (es) | 2013-11-22 | 2016-07-15 | Pharmakea Inc | Compuestos de inhibidor de autotaxina |
| AR098475A1 (es) | 2013-11-26 | 2016-06-01 | Bayer Cropscience Ag | Compuestos pesticidas y usos |
| AU2014356583B2 (en) | 2013-11-26 | 2019-02-28 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl |
| MA50635A (fr) * | 2014-03-26 | 2020-08-12 | Hoffmann La Roche | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
| CR20160418A (es) | 2014-03-26 | 2016-11-07 | Hoffmann La Roche | Nuevos compuestos biciclicos de 7 eslabones |
| JP2017515794A (ja) | 2014-03-26 | 2017-06-15 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 殺菌剤としての置換[1,2,4]トリアゾール及びイミダゾール化合物 |
| JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
| KR20160133004A (ko) | 2014-04-04 | 2016-11-21 | 엑스-알엑스, 인크. | 오토탁신의 치환된 스피로시클릭 억제제 |
| EP3187492A4 (fr) | 2014-08-29 | 2018-05-09 | The University of Tokyo | Dérivé de pyrimidone ayant une activité inhibitrice de l'autotaxine |
| SI3207043T1 (sl) | 2014-10-14 | 2019-04-30 | Vitae Pharmaceuticals, Inc. | Dihidropirolopiridinovi inhibitorji za ROR-gama |
| CA2975196A1 (fr) | 2015-02-15 | 2016-08-18 | F. Hoffmann-La Roche Ag | Derives de 1-(het)arylsulfonyle- (pyrrolidine ou piperidine)-2-carboxamide et leur utilisation comme antagonistes de trpa1 |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| WO2016181408A2 (fr) | 2015-05-11 | 2016-11-17 | Cadila Healthcare Limited | Nouveaux peptides à chaîne courte en tant qu'agonistes des récepteurs opioïdes kappa (κ) (kor) |
| CN104927727B (zh) | 2015-07-06 | 2017-01-11 | 香山红叶建设有限公司 | 一种玻璃幕墙用结构密封胶及其制备方法 |
| EP3344619B1 (fr) | 2015-09-04 | 2020-10-28 | H. Hoffnabb-La Roche Ag | Dérivés phénoxyméthyles |
| PL415078A1 (pl) | 2015-09-04 | 2017-03-13 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
| AU2016328437A1 (en) | 2015-09-24 | 2018-01-25 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
| MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| BR112018006080A2 (pt) | 2015-09-24 | 2018-10-09 | F. Hoffmann-La Roche Ag | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| HK1251624A1 (zh) | 2015-09-24 | 2019-02-01 | Ionis Pharmaceuticals, Inc. | Kras表达的调节剂 |
| WO2017050747A1 (fr) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs doubles d'atx/ca |
| WO2017087858A1 (fr) | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Composés de pyrazole, procédés de production et utilisation |
| US10323038B2 (en) | 2015-11-20 | 2019-06-18 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| CR20180336A (es) | 2015-11-25 | 2018-08-06 | Dana Farber Cancer Inst Inc | Inhibidores de bromodominio bivalentes y usos de los mismos |
| WO2017094750A1 (fr) | 2015-12-01 | 2017-06-08 | 日本農薬株式会社 | Composé de 3h-pyrrolopyridine ou son n-oxyde, ou leurs sels, insecticide agricole et horticole en contenant, et utilisation associée |
| WO2017139978A1 (fr) | 2016-02-19 | 2017-08-24 | 吴伟东 | Procédé et système d'actualisation d'application de téléphone mobile |
| RU2019132254A (ru) | 2017-03-16 | 2021-04-16 | Ф. Хоффманн-Ля Рош Аг | Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca |
| EP3596060B1 (fr) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| AR111295A1 (es) | 2017-03-20 | 2019-06-26 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr) |
-
2015
- 2015-03-23 MA MA050635A patent/MA50635A/fr unknown
- 2015-03-23 ES ES15711203T patent/ES2753549T3/es active Active
- 2015-03-23 PT PT157112038T patent/PT3122750T/pt unknown
- 2015-03-23 JP JP2016559180A patent/JP6553637B2/ja active Active
- 2015-03-23 UA UAA201610689A patent/UA118582C2/uk unknown
- 2015-03-23 MX MX2016012550A patent/MX370659B/es active IP Right Grant
- 2015-03-23 HU HUE15711203A patent/HUE046820T2/hu unknown
- 2015-03-23 CR CR20160419A patent/CR20160419A/es unknown
- 2015-03-23 LT LT15711203T patent/LT3122750T/lt unknown
- 2015-03-23 CN CN201910597241.1A patent/CN110204550B/zh active Active
- 2015-03-23 AU AU2015238537A patent/AU2015238537B2/en not_active Ceased
- 2015-03-23 RS RS20191366A patent/RS59477B1/sr unknown
- 2015-03-23 SG SG11201607839UA patent/SG11201607839UA/en unknown
- 2015-03-23 EA EA201691799A patent/EA037928B1/ru unknown
- 2015-03-23 CA CA2937616A patent/CA2937616A1/fr not_active Abandoned
- 2015-03-23 MA MA39792A patent/MA39792B1/fr unknown
- 2015-03-23 WO PCT/EP2015/056032 patent/WO2015144605A1/fr not_active Ceased
- 2015-03-23 EP EP19187080.7A patent/EP3590939A1/fr not_active Withdrawn
- 2015-03-23 HR HRP20191936TT patent/HRP20191936T1/hr unknown
- 2015-03-23 CN CN201580012770.0A patent/CN106103446B/zh active Active
- 2015-03-23 SI SI201530966T patent/SI3122750T1/sl unknown
- 2015-03-23 PE PE2016001550A patent/PE20161134A1/es unknown
- 2015-03-23 EP EP15711203.8A patent/EP3122750B1/fr active Active
- 2015-03-23 PL PL15711203T patent/PL3122750T3/pl unknown
- 2015-03-23 DK DK15711203T patent/DK3122750T3/da active
- 2015-03-23 KR KR1020167026271A patent/KR20160128345A/ko not_active Ceased
- 2015-03-25 TW TW104109650A patent/TWI708774B/zh not_active IP Right Cessation
- 2015-03-25 AR ARP150100865A patent/AR099824A1/es unknown
-
2016
- 2016-07-11 IL IL24670816A patent/IL246708B/en active IP Right Grant
- 2016-08-16 PH PH12016501632A patent/PH12016501632A1/en unknown
- 2016-09-14 CL CL2016002310A patent/CL2016002310A1/es unknown
- 2016-09-21 US US15/272,114 patent/US9802944B2/en active Active
-
2017
- 2017-09-27 US US15/717,724 patent/US20180111941A1/en not_active Abandoned
-
2018
- 2018-12-19 US US16/226,363 patent/US10654857B2/en active Active
-
2019
- 2019-07-04 JP JP2019125089A patent/JP2019189640A/ja active Pending
- 2019-08-08 PH PH12019501842A patent/PH12019501842A1/en unknown
- 2019-10-30 AU AU2019257457A patent/AU2019257457B2/en not_active Ceased
-
2020
- 2020-03-23 US US16/827,136 patent/US11098048B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20190217A1 (ar) | مركبات جديدة كمثبطات أوتوتاكسين وتركيبات صيدلانية تشتمل على هذه المركبات | |
| MX373236B (es) | Compuestos condensados de [1,4]diazepina como inhibidores de producción de la autotaxina (atx) y ácido lisofosfatidico (lpa). | |
| PH12016501632A1 (en) | Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors | |
| MA41562B1 (fr) | Agonistes d'apj 4-hydroxy-3-(heteroaryl)pyridine-2-one a utiliser dans le traitement de troubles cardio-vasculaires | |
| MA41185B1 (fr) | Composés d'acide isoxazole hydroxamique comme inhibiteurs de lpxc | |
| MA34909B1 (fr) | Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih | |
| PH12020551062A1 (en) | 1,2,4-oxadiazole compounds as inhibitors of cd47 signalling pathways | |
| MA39225A1 (fr) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tétrahydropyridines utilisées en tant qu'inhibiteurs de bace1 dans le traitement de la maladie d'alzheimer | |
| MA40955A (fr) | 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
| MA39777A (fr) | Composes organiques de la famille des monobactams pour le traitement d'infections bactériennes | |
| MA37439A1 (fr) | Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1). | |
| EA201691514A1 (ru) | Соединения | |
| MA44474B1 (fr) | Inhibiteurs de la ferroportine | |
| MA39554B1 (fr) | Spirocycloheptanes utilisés en tant qu'inhibiteurs de rock | |
| MA40123A1 (fr) | Pyrimidines utilisées en tant qu'inhibiteurs du facteur xia | |
| MA34797B1 (fr) | Hétéroaryles et leurs utilisations | |
| TN2015000347A1 (fr) | Azabenzimidazoles servant d'inhibiteurs d'isoenzymes pde4 pour le traitement de troubles du snc et d'autres troubles | |
| MA39317A1 (fr) | Dérivés de nucléosides à substitution 4'-difluorométhyle utilisés en tant qu'inhibiteurs de la réplication de l'arn du virus de la grippe | |
| MA39170A1 (fr) | Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer | |
| MA37666A1 (fr) | Sel de camsylate | |
| MA39337A1 (fr) | Modulateurs de pyrazines de gpr6 | |
| FR3007039B1 (fr) | Procede d'obtention d'un extrait de plante et compositions associees | |
| MA39374A1 (fr) | Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle | |
| MA40366A (fr) | Dérivés de tétrahydroquinoline à titre d'inhibiteurs des bromodomaines | |
| MX388014B (es) | Composición limpiadora líquida sin jabón que comprende ácido caprílico. |